Literature DB >> 25777295

Umbilical Cord Blood-Derived Mononuclear Cells Exhibit Pericyte-Like Phenotype and Support Network Formation of Endothelial Progenitor Cells In Vitro.

Erica B Peters1, Betty Liu2, Nicolas Christoforou2, Jennifer L West2, George A Truskey2.   

Abstract

Umbilical cord blood represents a promising cell source for pro-angiogenic therapies. The present study examined the potential of mononuclear cells (MNCs) from umbilical cord blood to support endothelial progenitor cell (EPC) microvessel formation. MNCs were isolated from the cord blood of 20 separate donors and selected for further characterization based upon their proliferation potential and morphological resemblance to human vascular pericytes (HVPs). MNCs were screened for their ability to support EPC network formation using an in vitro assay (Matrigel™) as well as a reductionist, coculture system consisting of no additional angiogenic cytokines beyond those present in serum. In less than 15% of the isolations, we identified a population of highly proliferative MNCs that phenotypically resembled HVPs as assessed by expression of PDGFR-β, NG2, α-SMA, and ephrin-B2. Within a Matrigel™ system, MNCs demonstrated pericyte-like function through colocalization to EPC networks and similar effects as HVPs upon total EPC tubule length (p = 0.95) and number of branch points (p = 0.93). In a reductionist coculture system, MNCs served as pro-angiogenic mural cells by supporting EPC network formation to a significantly greater extent than HVP cocultures, by day 14 of coculture, as evidenced through EPC total tubule length (p < 0.0001) and number of branch points (p < 0.0001). Our findings are significant as we demonstrate mural cell progenitors can be isolated from umbilical cord blood and develop culture conditions to support their use in microvascular tissue engineering applications.

Entities:  

Keywords:  Angiogenesis; Microvessel formation; Progenitor cells; Tissue engineering; Umbilical cord blood; Vasculogenesis

Mesh:

Substances:

Year:  2015        PMID: 25777295      PMCID: PMC4573271          DOI: 10.1007/s10439-015-1301-z

Source DB:  PubMed          Journal:  Ann Biomed Eng        ISSN: 0090-6964            Impact factor:   3.934


  47 in total

1.  Isolation of multipotent mesenchymal stem cells from umbilical cord blood.

Authors:  Oscar K Lee; Tom K Kuo; Wei-Ming Chen; Kuan-Der Lee; Shie-Liang Hsieh; Tain-Hsiung Chen
Journal:  Blood       Date:  2003-10-23       Impact factor: 22.113

Review 2.  Endothelial/pericyte interactions.

Authors:  Annika Armulik; Alexandra Abramsson; Christer Betsholtz
Journal:  Circ Res       Date:  2005-09-16       Impact factor: 17.367

3.  In vivo vasculogenic potential of human blood-derived endothelial progenitor cells.

Authors:  Juan M Melero-Martin; Zia A Khan; Arnaud Picard; Xiao Wu; Sailaja Paruchuri; Joyce Bischoff
Journal:  Blood       Date:  2007-02-27       Impact factor: 22.113

Review 4.  Molecular control of endothelial cell behaviour during blood vessel morphogenesis.

Authors:  Shane P Herbert; Didier Y R Stainier
Journal:  Nat Rev Mol Cell Biol       Date:  2011-08-23       Impact factor: 94.444

5.  Isolation and characterization of mesenchymal stem cells from human umbilical cord blood: reevaluation of critical factors for successful isolation and high ability to proliferate and differentiate to chondrocytes as compared to mesenchymal stem cells from bone marrow and adipose tissue.

Authors:  Xiaohong Zhang; Masako Hirai; Susana Cantero; Rodica Ciubotariu; Ludy Dobrila; Allen Hirsh; Koichi Igura; Hitoshi Satoh; Izuru Yokomi; Toshihide Nishimura; Satoru Yamaguchi; Kotaro Yoshimura; Pablo Rubinstein; Tsuneo A Takahashi
Journal:  J Cell Biochem       Date:  2011-04       Impact factor: 4.429

Review 6.  Assessing identity, phenotype, and fate of endothelial progenitor cells.

Authors:  Karen K Hirschi; David A Ingram; Mervin C Yoder
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-07-31       Impact factor: 8.311

Review 7.  Umbilical cord blood transplantation: pros, cons and beyond.

Authors:  Anfisa Stanevsky; Gal Goldstein; Arnon Nagler
Journal:  Blood Rev       Date:  2009-03-17       Impact factor: 8.250

8.  Thrombospondin signaling through the calreticulin/LDL receptor-related protein co-complex stimulates random and directed cell migration.

Authors:  A Wayne Orr; Carrie A Elzie; Dennis F Kucik; Joanne E Murphy-Ullrich
Journal:  J Cell Sci       Date:  2003-07-15       Impact factor: 5.285

9.  Mural cell associated VEGF is required for organotypic vessel formation.

Authors:  Lasse Evensen; David R Micklem; Anna Blois; Sissel Vik Berge; Niels Aarsaether; Amanda Littlewood-Evans; Jeanette Wood; James B Lorens
Journal:  PLoS One       Date:  2009-06-04       Impact factor: 3.240

10.  Donor age and cell passage affects differentiation potential of murine bone marrow-derived stem cells.

Authors:  James D Kretlow; Yu-Qing Jin; Wei Liu; Wen Jie Zhang; Tan-Hui Hong; Guangdong Zhou; L Scott Baggett; Antonios G Mikos; Yilin Cao
Journal:  BMC Cell Biol       Date:  2008-10-28       Impact factor: 4.241

View more
  7 in total

Review 1.  Endothelial Progenitor Cells for the Vascularization of Engineered Tissues.

Authors:  Erica B Peters
Journal:  Tissue Eng Part B Rev       Date:  2017-07-03       Impact factor: 6.389

2.  Poly(ethylene glycol) Hydrogel Scaffolds Containing Cell-Adhesive and Protease-Sensitive Peptides Support Microvessel Formation by Endothelial Progenitor Cells.

Authors:  Erica B Peters; Nicolas Christoforou; Kam W Leong; George A Truskey; Jennifer L West
Journal:  Cell Mol Bioeng       Date:  2015-10-20       Impact factor: 2.321

3.  Significant improvement of direct reprogramming efficacy of fibroblasts into progenitor endothelial cells by ETV2 and hypoxia.

Authors:  Phuc Van Pham; Ngoc Bich Vu; Hoa Trong Nguyen; Oanh Thuy Huynh; Mai Thi-Hoang Truong
Journal:  Stem Cell Res Ther       Date:  2016-08-04       Impact factor: 6.832

Review 4.  Perinatal Brain Injury As a Consequence of Preterm Birth and Intrauterine Inflammation: Designing Targeted Stem Cell Therapies.

Authors:  Madison C B Paton; Courtney A McDonald; Beth J Allison; Michael C Fahey; Graham Jenkin; Suzanne L Miller
Journal:  Front Neurosci       Date:  2017-04-10       Impact factor: 4.677

5.  Autologous Umbilical Cord Blood-Derived Mononuclear Cell Therapy Promotes Cardiac Proliferation and Adaptation in a Porcine Model of Right Ventricle Pressure Overload.

Authors:  Saji Oommen; Susana Cantero Peral; Muhammad Y Qureshi; Kimberly A Holst; Harold M Burkhart; Matthew A Hathcock; Walter K Kremers; Emma B Brandt; Brandon T Larsen; Joseph A Dearani; Brooks S Edwards; Joseph J Maleszewski; Timothy J Nelson
Journal:  Cell Transplant       Date:  2022 Jan-Dec       Impact factor: 4.139

6.  Stem cell therapy targeting the right ventricle in pulmonary arterial hypertension: is it a potential avenue of therapy?

Authors:  Fanny Loisel; Bastien Provost; François Haddad; Julien Guihaire; Myriam Amsallem; Bojan Vrtovec; Elie Fadel; Georges Uzan; Olaf Mercier
Journal:  Pulm Circ       Date:  2018-02-26       Impact factor: 3.017

7.  Development of a Novel Pre-Vascularized Three-Dimensional Skin Substitute Using Blood Plasma Gel.

Authors:  Niann-Tzyy Dai; Wen-Shyan Huang; Fang-Wei Chang; Lin-Gwei Wei; Tai-Chun Huang; Jhen-Kai Li; Keng-Yen Fu; Lien-Guo Dai; Pai-Shan Hsieh; Nien-Chi Huang; Yi-Wen Wang; Hsin-I Chang; Roxanne Parungao; Yiwei Wang
Journal:  Cell Transplant       Date:  2018-09-11       Impact factor: 4.064

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.